Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/15/2010CN101283979B Preparation method of hyaluronic acid small fragment plaster for promoting the wound healing
12/15/2010CN101249190B Anti-inflammation sterilizing Chinese medicine compound externally used coating liquid and method of preparing the same
12/15/2010CN101249170B Preparation of houttuynia cordata freeze-dried powder needle for injections
12/15/2010CN101234163B , preparation method of Chinese medicine composition for treating kidney deficiency and stasis resistance syndrome
12/15/2010CN101234140B Pharmaceutical composition for curing eczema and preparation and application thereof
12/15/2010CN101229194B Medicine for treating gall-stone, nephrolith and lithangiuria, preparing method thereof
12/15/2010CN101214337B Chinese medicinal composition for treating stomach and duodenal ulcer and preparation
12/15/2010CN101204474B Tincture medicine for wrick
12/15/2010CN101199695B Powders medicament for treating sinusitis
12/15/2010CN101194935B Traditional Chinese medicine preparation for treating acute upper respiratory tract infection and method for preparing the same
12/15/2010CN101181483B Chinese patent drug for curing cataptosis and hemiparalysis sequela
12/15/2010CN101181388B Mass control method of keke oral preparation
12/15/2010CN101181306B Nano-scale compound pearl dimension C lozenge and preparation method thereof
12/15/2010CN101176722B Scutellaria glycosides freeze dried injection solution and preparation method thereof
12/15/2010CN101161278B A relieving cough dropping pills and its preparing method
12/15/2010CN101143164B Medicinal composition for treating coronary heart disease and preparation process thereof
12/15/2010CN101138581B Traditional chinese medicine preparation for treating urinary system infection contamination and method of preparing the same
12/15/2010CN101125147B Glucosamine calcium medicine preparation, preparation method and application thereof
12/15/2010CN101099859B New use of leuprorelin acetate in delaying senility and preventing climacteric syndrome
12/15/2010CN101085111B Acne-eliminating capsule
12/15/2010CN101057909B Composition with multiple health care functions and its preparation method
12/15/2010CN101041011B Chinese traditional medicine for preventing and curing AIDS
12/15/2010CN101040880B Method for preparing myrica seed oil capsule
12/15/2010CN101028414B Externally-applied medicine for treating diarrhea and its production
12/15/2010CN101007017B Extract of traditional Chinese medicine having alpha-glucosidase inhibitor activity and its application
12/14/2010USRE41996 Composition and methods for enhancing receptor-mediated cellular internalization
12/14/2010US7851595 Membrane fusion proteins derived from reoviridae for use in delivery of bioactive drugs to cells
12/14/2010US7851512 dosage form containing artemisinin1 part, piperaquine 3-9 parts primaquine up to 0.2 parts and adjuvants formulated into tablets or granules, suppositories, suspension syrup or dry powder for pediatric use
12/14/2010US7851511 Emulsifier for highly liquid W/O emulsion based on partly crosslinked polyglycerol esters of polyhydroxystearic acid
12/14/2010US7851506 orally administering sodium oxybate a dosage form, to a patient, suffering from apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus
12/14/2010US7851483 Medicaments comprising steroids and a novel anticholinergic
12/14/2010US7851458 Cartilage enhancing food supplements and methods of preparing the same
12/14/2010US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
12/14/2010US7850997 Dietary compositions and methods of enhancing lean body mass and exercise performance
12/14/2010US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery
12/14/2010US7850994 release active compounds at predictable rates and may provide such release for relatively long periods of time; Orthopedic and trauma uses; drug delivery
12/14/2010US7850993 Drug-releasing system of biodegradable polymer type
12/14/2010US7850992 also contains a pharmacologically active substance and a stimulus-responsive compound comprising an azobenzene group or a stilbene group
12/14/2010US7850991 Calcium formate for use as a dietary supplement
12/14/2010US7850990 Compositions for delivery of drug combinations
12/14/2010US7850989 Critical care for neonatal calves
12/14/2010US7850988 Calcium carbonate granulation
12/14/2010US7850983 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
12/14/2010US7850982 terpolymer comprising polyoxyalkylene copolymer, polycaprolactone, with copolymerizable monomers such as glycolide, lactide, p-dioxanone and trimethylene carbonate; surgical sutures; for coating medical equipment
12/14/2010US7850974 Using sequences infomation to identify microbial surface components recognizing adhesive matrix molecules (MSCRAMM proteins) in order to diagnose, treat and prevent bacterial infection
12/14/2010US7850956 Immunization by inoculation of DNA transcription unit
12/14/2010US7850641 Safety limits for closed-loop infusion pump control
12/14/2010CA2591867C Cooling topical patch preparation
12/14/2010CA2504874C Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system
12/14/2010CA2478811C Tasted masked veterinary solid compositions
12/14/2010CA2462376C Liposome loading with metal ions
12/14/2010CA2461890C Water soluble nanoparticles of hydrophilic and hydrophobic active materials
12/14/2010CA2459472C Sustained release micropellets and process for producing the same
12/14/2010CA2438339C Use of buprenorphine for treatment of urinary incontinence
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2420292C Contraception process and administration form for the same
12/14/2010CA2414941C Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
12/14/2010CA2411944C The combination of antimicrobial agents and bacterial interference to coat medical devices
12/14/2010CA2309633C Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/14/2010CA2207615C Spray dried erythropoietin
12/14/2010CA2152917C Liposome with oligosaccharide on surface
12/09/2010WO2010141956A2 Methods and compositions for the treatment of cancer
12/09/2010WO2010141938A1 Combination of dopamine agonists plus first phase insulin secretagouges for the treatment of metabolic disorders
12/09/2010WO2010141879A2 Peptides for transport of therapeutics and their carriers in mouse models and humans
12/09/2010WO2010141806A2 Compositions and methods for delivery of materials
12/09/2010WO2010141667A1 Therapeutic agent delivery system and method
12/09/2010WO2010141591A1 Omega-3 oil containing ophthalmic emulsions
12/09/2010WO2010141588A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol
12/09/2010WO2010141586A2 Therapeutic ophthalmic emulsions
12/09/2010WO2010141475A1 Compositions and methods for preventing sternal wound infections
12/09/2010WO2010141191A1 Method to stabilize a dietary supplement comprising glucosamine
12/09/2010WO2010140992A1 Stable pharmaceutical compositions containing rosuvastatin calcium
12/09/2010WO2010140987A1 Multi-phase microparticles and method of manufacturing multi-phase microparticles
12/09/2010WO2010140869A2 Complex, multilayer using the same, and device coated with the multilayer
12/09/2010WO2010140855A2 Pharmaceutical composition or functional food composition for the treatment, prevention or alleviation of cardiac hypertrophy comprising raspberry extract
12/09/2010WO2010140686A1 Emulsifying preparation
12/09/2010WO2010140401A1 Microneedle array using porous substrate and process for producing same
12/09/2010WO2010140377A1 Vaccine for mycoplasma infection
12/09/2010WO2010140170A1 Topical micro-emulsions for the treatment of rheumatic disorders
12/09/2010WO2010140151A1 Device and method for adjusting basal delivery profile
12/09/2010WO2010140111A1 Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
12/09/2010WO2010140061A2 Formulations for the treatment of deep tissue pain
12/09/2010WO2010140007A2 Dosage form
12/09/2010WO2010139954A1 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
12/09/2010WO2010139752A2 Stabilised composition comprising at least one adrenergic compound
12/09/2010WO2010139751A2 Stabilised composition comprising at least one adrenergic compound
12/09/2010WO2010139278A1 Preparation method of drug loaded emulsion
12/09/2010WO2010139252A1 Use of isothiocyanates for promoting growth of hairs
12/09/2010WO2010139111A1 Sustained release dosage form
12/09/2010WO2010139061A1 Immuno-compatible hydrogel system
12/09/2010WO2010139003A1 Chelating amphiphiles
12/09/2010WO2010117089A3 Antimycotic pharmaceutical composition
12/09/2010WO2010115947A3 Prolonged-release alfa-lipoic acid
12/09/2010WO2010095875A3 Patch for treating constipation using crude drugs
12/09/2010WO2010093460A3 Particle size-structured parenteral dispersions
12/09/2010WO2010083239A3 Therapeutic modulation of vaginal epithelium boundary lubrication
12/09/2010WO2010083129A9 Implantable delivery vehicle for ocular delivery of muscarinic antagonists
12/09/2010WO2010042152A3 Amorphous rotigotine transdermal system
12/09/2010WO2010002613A3 Method of making a dry powder pharmaceutical composition
1 ... 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 ... 2991